Sanofi’s pipeline contains a dozen opportunities with “blockbuster” potential, its CEO Paul Hudson says, if only investors have the stomach to see the company’s research and development bear fruit.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,